SMAD4 and pancreatic adenocarcinoma: Smad4 mutations are found in approximately 50% of pancreatic adenocarcinomas (Howe et al., 1998), 20% of colorectal cancers (Chu et al., 2004) and 5% of head and neck squamous cell carcinomas (Lin et al., 2019).